Skip to main content
OpenTrials

Clinical trial condition

Urticaria

Explore clinical trials studying Urticaria. Study availability and eligibility vary by location and protocol.

320 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Urticaria trial results

Completed

A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route

NCT01576523

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +9 more
Locations
  • Study Site Atlanta, Georgia, United States
  • Study Site Chevy Chase, Maryland, United States
  • Study Site Cincinnati, Ohio, United States
  • Study Site Toledo, Ohio, United States
View Trial Details
Completed

A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema

NCT01912456

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Study Site Birmingham, Alabama, United States
  • Study Site Scottsdale, Arizona, United States
  • Study Site Bell Gardens, California, United States
  • Study Site La Jolla, California, United States
View all 39 locations
View Trial Details
Completed

Study of Efficacy and Safety of Xolair® (Omalizumab) in Chinese Patients With Chronic Spontaneous Urticaria

NCT03328897

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Novartis Investigative Site Beijing, Beijing Municipality, China
  • Novartis Investigative Site Fuzhou, Fujian, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Nanning, Guangxi, China
View all 27 locations
View Trial Details
Completed

Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to Therapy

NCT01723072

Conditions
Angioedema, Cardiovascular Diseases, Chronic Disease, +13 more
Locations
  • Novartis Investigative Site Mannheim, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Regensburg, Bavaria, Germany
  • Novartis Investigative Site Cologne, North Rhine-Westphalia, Germany
  • Novartis Investigative Site Aachen, Germany
View all 25 locations
View Trial Details
Completed

Omalizumab in Chronic Spontaneous Urticaria Patients Non Responding to Initial Standard antihistaminE Treatment

NCT02550106

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Novartis Investigative Site Paris, Cedex 10, France
  • Novartis Investigative Site Limoges, Haute Vienne, France
  • Novartis Investigative Site Toulon, Val De Marne, France
  • Novartis Investigative Site Angers, France
View all 29 locations
View Trial Details

Related conditions